India Glycols Limited Receives Favorable Appellate Order, Penalty Reduced from Rs.7,20,570 to Rs.10,000

1 min read     Updated on 15 Apr 2026, 10:53 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

India Glycols Limited has received a favorable appellate order from the Deputy Commissioner of State Tax, Appeal-4, (Mehsana) Gujarat, dated April 15, 2026. The appellate authority set aside the original penalty of Rs.7,20,570 (IGST) and imposed a reduced penalty of Rs.10,000 (IGST) for a clerical mistake in E-way bill documentation. The company has decided not to pursue further appeal considering the minimal penalty amount versus litigation costs, resulting in a net relief of Rs.7,10,570.

powered bylight_fuzz_icon
37819418

*this image is generated using AI for illustrative purposes only.

India Glycols Limited has received significant relief in its tax penalty appeal, with the appellate authority substantially reducing the penalty amount from Rs.7,20,570 to Rs.10,000. The company disclosed this development through a regulatory filing under Regulation 30 of SEBI Listing Regulations on April 15, 2026.

Appellate Order Details

The Deputy Commissioner of State Tax, Appeal-4, (Mehsana) Gujarat passed the appellate order on April 15, 2026, addressing the company's appeal against the original penalty imposed on November 25, 2024. The appellate authority's decision provided substantial relief to the company by setting aside the majority of the penalty amount.

Parameter Details
Appellate Authority Deputy Commissioner of State Tax, Appeal-4, (Mehsana) Gujarat
Order Date April 15, 2026
Original Penalty Set Aside Rs.7,20,570 (IGST)
New Penalty Imposed Rs.10,000 (IGST)
Reason for New Penalty Clerical mistake of not disclosing tax amount in E-way bill

Background and Violation Details

The case originated from an order dated November 25, 2024, passed by the State Tax Officer (Mobile Squad, Amirgadh), which had imposed a penalty of Rs.7,20,570 on the company. The appellate authority found merit in the company's appeal and set aside this entire penalty amount.

However, the appellate authority identified a clerical mistake in the company's E-way bill documentation, specifically the non-disclosure of tax amount, which resulted in the imposition of a new penalty of Rs.10,000 (IGST).

Company's Strategic Decision

India Glycols Limited has taken a pragmatic approach regarding the reduced penalty amount. The company believes that the penalty of Rs.10,000 imposed for the clerical mistake is not valid. However, after considering the quantum of penalty amount versus the cost of litigation, the company has decided not to file an appeal against this order.

Financial Impact

The financial impact on the company has been significantly reduced from the original penalty amount:

Impact Assessment Amount
Original Penalty Rs.7,20,570
Final Penalty Rs.10,000
Net Relief Rs.7,10,570

This represents a reduction of over 98% from the original penalty amount, providing substantial financial relief to the company. The company has disclosed that the current penalty amount of Rs.10,000 will not have any material impact on its financial, operational, or other activities.

Historical Stock Returns for India Glycols

1 Day5 Days1 Month6 Months1 Year5 Years
+3.03%+5.35%+12.83%-0.23%+40.06%+324.87%

Will this favorable appellate outcome encourage India Glycols to challenge similar tax penalties more aggressively in future cases?

How might this significant penalty reduction impact India Glycols' compliance processes and E-way bill documentation procedures going forward?

Could this appellate precedent influence other companies facing similar GST penalties to pursue appeals rather than accepting original penalty amounts?

India Glycols Receives NCLT Approval for Second Motion in Demerger Scheme

2 min read     Updated on 11 Apr 2026, 05:49 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

India Glycols Limited has received NCLT Allahabad approval for its second motion petition in the demerger scheme involving Ennature Biopharma Limited and IGL Spirits Limited. The order dated 9th April, 2026 directs newspaper publications and regulatory notices with 30-day response period. The next hearing is scheduled for 21st May, 2026, marking significant progress in the corporate restructuring process.

powered bylight_fuzz_icon
37412396

*this image is generated using AI for illustrative purposes only.

India Glycols Limited has achieved a significant milestone in its corporate restructuring journey with the National Company Law Tribunal (NCLT) Allahabad admitting its second motion petition for a scheme of arrangement. The order dated 9th April, 2026, made available online on 10th April, 2026, represents a crucial step forward in the company's planned demerger.

NCLT Order Details

The NCLT has admitted the second motion petition filed under Sections 230 to 232 of the Companies Act, 2013, in relation to the scheme of arrangement among India Glycols Limited (Demerged Company), Ennature Biopharma Limited (Resulting Company 1), and IGL Spirits Limited (Resulting Company 2). This follows the company's earlier intimation dated 24th March, 2026, regarding the outcome of meetings of equity shareholders and unsecured creditors.

Parameter: Details
Order Date: 9th April, 2026
Tribunal: NCLT Allahabad Bench at Prayagraj
Case Number: CP (CAA) No.07/ALD/2026 IN CA (CAA) No.36/ALD/2025
Next Hearing: 21st May, 2026

Regulatory Compliance Requirements

The NCLT has directed India Glycols to undertake several compliance measures as part of the approval process. The company must make newspaper publications in Business Standard (English) and Amar Ujala (Hindi), ensuring wide circulation in areas where the registered office is located. Additionally, notices must be issued to various regulatory authorities as specified under Section 230(5) of the Companies Act, 2013.

Key regulatory bodies that will receive notices include:

  • Central Government through Ministry of Corporate Affairs
  • Regional Director, Ministry of Corporate Affairs
  • Registrar of Companies, Uttarakhand
  • Income Tax authorities including Principal Chief Commissioner of Income Tax, Lucknow
  • Securities and Exchange Board of India
  • National Stock Exchange of India Limited
  • BSE Limited

Scheme Structure and Timeline

The demerger scheme involves three entities with specific roles in the corporate restructuring. India Glycols Limited serves as the demerged company, while Ennature Biopharma Limited and IGL Spirits Limited will function as the two resulting companies post-demerger.

Company: Role CIN
India Glycols Limited: Demerged Company L24111UR1983PLC009097
Ennature Biopharma Limited: Resulting Company 1 U24290UR2021PLC013005
IGL Spirits Limited: Resulting Company 2 U11011UT2024PLC018229

All regulatory authorities have been given 30 days from receipt of notice to submit their representations. If no objections are received within this timeframe, it will be presumed that the authorities have no objections to the proposed scheme.

Next Steps and Proceedings

The matter is now scheduled for further hearing on 21st May, 2026. The company has been directed to file affidavits evidencing proof of service and publication compliance at least 7 days before the hearing date. The NCLT registry will also report on any objections received from the public pursuant to the newspaper publication of the hearing notice.

The scheme remains subject to applicable regulatory and other approvals. A certified copy of the order is awaited, and the complete order has been made available on the company's website for stakeholder reference. This development represents continued progress in India Glycols' strategic corporate restructuring initiative.

Historical Stock Returns for India Glycols

1 Day5 Days1 Month6 Months1 Year5 Years
+3.03%+5.35%+12.83%-0.23%+40.06%+324.87%

How will the demerger impact India Glycols' market valuation and what share allocation ratio can shareholders expect between the three entities?

What strategic advantages does splitting into pharma and spirits divisions offer compared to India Glycols' current integrated business model?

Will the newly formed Ennature Biopharma and IGL Spirits require separate stock exchange listings and how might this affect trading liquidity?

More News on India Glycols

1 Year Returns:+40.06%